Allergic contact dermatitis (ACD) is a widespread hypersensitivity reaction of the skin. The cellular mechanisms underlying its development are complex and involve close interaction of different cell types of the immune system. It is this very complexity which has long prevented straightforward replacement of the corresponding regulatory in vivo tests. Recent efforts have already resulted in the development of several in vitro testing alternatives that address key steps of ACD. Yet identification of suitable biomarkers is still a subject of intense research. Search strategies for the latter encompass transcriptomics, proteomics as well as metabolomics approaches. The scope of this review shall be the application and use of proteomics in the context of ACD. This includes highlighting relevant aspects of the molecular and cellular mechanisms underlying ACD, the exploitation of these mechanisms for testing and biomarkers (e.g., in the context of the OECD's adverse outcome pathway initiative) as well as an outlook on emerging proteome targets, for example during the allergen-induced activation of dendritic cells (DCs). † Both authors contributed equally.
Molecular and cellular mechanisms
Allergic contact dermatitis (ACD) is a skin disease that may be elicited after skin contact with triggers such as organic chemicals or metals (i.e., as a result of exposure to cosmetics, jewellery or other commodities with skin contact). The global prevalence of ACD to at least one contact allergen is estimated to be about 20%. 1 The underlying immune response is a T cell mediated delayed-type hypersensitivity. Pathogenesis of ACD is sub-divided in two phases. The first one, that is sensitisation, is initiated following the first exposure to a contact allergen and will pass without any clinical symptoms. The second phase, that is the so-called elicitation phase, will only emerge after re-exposure to the same substance. 2 Generally, contact allergens are electrophilic chemicals of low molecular weight which bind to nucleophilic regions of cellular macromolecules such as proteins. There are over 4000 substances which may act as protein-binding haptens. 3 Other chemicals are not directly protein-reactive but will require metabolic or abiotic activation for their conversion to an immunologically reactive form. They are referred to as prohaptens or prehaptens, respectively.
Protein modification during haptenation is substantial and comprises the covalent binding of chemicals as well as the formation of metal complexes. Main sites of modification are the sulfhydryl and imidazole groups of cysteines and histidines, respectively, as well as the more exposed amino groups of lysine or N-termini in general. 4 In order to bind to the corresponding epidermal protein residues contact sensitisers need to penetrate the stratum corneum. Accordingly, most contact allergens share hydrophobic properties. Co-exposure to irritants can impact the skin barrier function further and thus enhance penetration as can skin abrasion. Likewise exposure to structurally similar substances can lead to sensitisation and subsequent contact allergy. 5 Little is known about the exact binding sites of haptens in human skin and the abundance of generated modifications though. While it might seem reasonable to assume that potent side chain modificators lead to the formation of more antigens, the modification of key amino acids (e.g., in the active site of proteins) might well prove to be more effective for the initiation of a pronounced immune response.
The predominant cell type of the epidermis is keratinocytes and it is them which create an effective barrier against exogenous agents. In this function they do not normally present antigens on their cell surface. Yet, they can be subject to haptenation, metabolically activate prohaptens and modulate an immune response by the secretion of pro-inflammatory second messengers. Cytokines such as IL-1α, IL-1β and IL-18 are fundamental in the induction of ACD and the activation of other involved cells, for example dendritic cells (DCs) and T cells. Importantly, the sensitisation phase of ACD requires skin inflammation, which is triggered by the contact allergens that also have irritant and adjuvant properties. 6 In the steady state two major subsets of DCs are located in the skin. These are the so-called Langerhans cells (LCs) in the epidermis and dermal DCs. 7 The latter represent the most potent antigen presenting cells (APCs). They are able to ingest antigens via phagocytosis and to present the respective processed peptide fragments on major histocompatibility complex (MHC) molecules. In the skin DCs are resident in their immature form (iDCs). Ingestion of an antigen together with other molecular and cellular stimuli leads to DC activation and maturation. 8 They subsequently migrate to the local lymph nodes where they prime antigen-specific CD4 + and CD8 + T cells ( Fig. 1) . At the same time the phagocytic activity of activated DCs is noticeably reduced due to the loss of phagocytosis receptors during the maturation process. 9 The activation of DCs is accompanied by phenotypic alterations of the cell surface proteome as well as the production and release of second messengers such as IL-12. 10 The phenotypic alterations emerge from the expression of adhesion molecules like CD54 and the expression of co-stimulatory molecules, namely CD86, CD80, CD83 and CD40, that enhance the priming of naïve T cells. 11, 12 Once maturation is completed DCs are referred to as mature dendritic cells (mDCs).
T cells are the effectors during ACD. Naïve CD4 + and CD8 + T cells are primed to become Th1 and Th17 as well as cytotoxic Tc1 and Tc17, respectively. 13, 14 It is CD4 + -derived regulatory T cells that mediate the immune response during ACD. 15 However, since T cells cannot recognise naked allergens they depend on antigen presentation by cells such as DCs. Naïve T cells will recognise the MHC-bound allergen via their T cell receptor. The essential stimulation of the T cell receptor is supported by co-stimulatory molecules, for example CD86 as well as cytokines such as IL-12, both of which are expressed on and secreted by DCs, respectively. Fully activated T cells on the other hand secrete inflammatory mediators like IFN-γ. During sensitisation antigen-specific T effector cells migrate to the affected tissue where some are transformed into resting T memory cells. Any subsequent challenge with the contact allergen during elicitation then triggers secretion of IFN-γ which supports rapid and efficient proliferation as well as recruitment of antigen-specific T effector cells. 13 Antigen specific T cells then infiltrate the affected tissue, thereby inducing an inflammatory response which in turn leads to the typical clinical symptoms (i.e., burning or red and itchy rashes).
Irritants such as sodium dodecyl sulfate (SDS) may cause similar cellular cytokine expression profiles. 16, 17 They even might stimulate T cell activation and recruitment. However, the corresponding T cell response is not chemical specific. Unsurprisingly the clinical symptoms of ACD and irritant contact dermatitis (ICD) are in general very similar. However, unlike ACD ICD does not require sensitisation and thus clinical symptoms are rapidly induced after first exposure.
The toxicological concern of skin sensitisation Given that ACD puts a high burden on affected subjects as well as on the society it is of high toxicological concern, the more so as the irreversibility of sensitisation makes it a life-long condition. 8 In order to prevent ACD toxicological testing thus focuses on sensitisation and the early detection of potential sensitisers. The sensitisation potency of contact allergens was traditionally determined using well established in vivo methods like the guinea pig maximisation test (GPMT) 18, 19 or the local lymph node assay (LLNA). 20, 21 The latter measures the proliferation of murine lymphocytes in draining lymph nodes subsequent to treatment with potential contact allergens. Due to its ease of use, high reproducibility and accuracy the LLNA quickly became the gold standard for evaluation and classification of contact allergens. However, latest since the European Union's ban of animal testing on cosmetic product ingredients, including the distribution of products containing such ingredients, 22, 23 there is an urgent necessity to find reliable in vitro testing alternatives. In order to facilitate the development and implementation of alternative tests the OECD has proposed an adverse outcome pathway (AOP) for skin sensitisation. Within this AOP four key events have been defined which, if appropriately covered by in vitro tests, should reliably inform about a substance's allergenic potential. The key events comprise firstly haptenation, secondly the activation of keratinocytes, thirdly the activation of dendritic cells and lastly the proliferation of T cells (Fig. 2 ). 24 Fig. 1 Sketch depicting the cellular and molecular biology of sensitisation and elicitation, respectively. During sensitisation contact allergens penetrate into the skin and then bind to proteins or to TLRs on iDCs. Coincidentally keratinocytes become activated and produce inflammatory cytokines, while iDCs internalise modified proteins by phagocytosis. After processing of haptenated self-proteins mDCs present antigens on their surface via MHCII and migrate to the draining lymph nodes where they select and prime naïve T cells. Primed T cells then proliferate and eventually re-migrate to the skin where they reside as memory effector T cells. Upon re-exposure during elicitation immediate T cell activation at the site of exposure leads to the release of inflammatory cytokines which finally results in the development of contact eczema.
Currently, there are three alternative assays available that have been validated according to the European Union Reference Laboratory's (EURL ECVAM) guidelines and were subsequently adopted as OECD testing guidelines: the direct peptide reactivity assay (DPRA, OECD TG 442C), 25 the KeratinoSens™ assay (OECD TG 442D) 26 and the human Cell Line Activation Test (h-CLAT, OECD TG 442E). 27 The DPRA is designed to simulate the haptenation process by estimating the reactivity of electrophiles towards nucleophilic model peptides in chemico, 28 while the KeratinoSens™ addresses the second key event and aims to mimic the activation of keratinocytes by contact allergens. It uses an antioxidant response element (ARE) coupled luciferase assay for the sensing of contact allergen specific activation of Nrf2, which is a key regulator of the keratinocytic inflammatory response. The transcription factor Nrf2 is mostly known for its regulatory role in a variety of cytoprotective pathways including phase II metabolism and antioxidant defense as well as for its involvement in the regulation of basic cellular processes such as protein degradation, metabolism and cell growth. 29 However, Nrf2 also regulates parts of the allergenic immune response where activation by electrophilic substances leads to its binding and induction of ARE-containing promoter regions. [30] [31] [32] Since nonallergens do not trigger the ARE pathway this can be used in vitro to distinguish between potential sensitisers and nonsensitisers. 33 The third assay is the h-CLAT which quantifies changes in the expression of the cell surface markers CD54 and CD86 in human THP-1 cells after test substance treatment, hence trying to mimic the activation of DCs. 34 While the single tests perform reasonably well they suffer from the intrinsic caveat that they try to mimic a whole body immune response based on readouts from selected cellular substitutes. This subjects their regulatory performance to limitations, one being their limited compatibility with the potency categorisation as requested by the Globally Harmonised System of Classification and Labelling of Chemicals (GHS). While most assays do allow potency predictions to some extent, the respective potency classes tend to vary between different in vitro assays. Moreover, the classification frequently differs from LLNA by one category. 35 Finally, the correct identification of pre-and prohaptens like isoeugenol or p-phenylenediamine (PPD) is another major challenge. On the one hand cell culture based in vitro assays often do not provide the physicochemical milieu needed for spontaneous haptenation. On the other hand their metabolic capacity also differs from that found in skin in vivo. Yet, up to 20-25% of all sensitisers belong to chemical groups that require some form of pre-activation. 36, 37 The sensitivity for correct identification of pre-and prohaptens was recently reported to be 81% performing a 2 out of 3 experiment with the three OECD guideline tests. 38 Inclusion of further although unvalidated assays led to similar sensitivities. 37 Thus, current research efforts now focus on the addition of further assays in order to improve the test batteries performance.
Although the proteome of the skin undergoes essential changes at the site of exposure to an allergen, it is striking that in vitro biomarkers which are indicative and specific for ACD beyond activation are rare. 35, 39 Modification of the skin proteome occurs for example as a result of covalent binding of sensitisers, the ingestion, processing and presentation of antigens by DCs as well as on the cellular level during DC activation or migration. Due to rapid technological development over the past years, high resolution mass spectrometry nowadays provides a powerful tool to investigate modified and regulated proteins during ACD which can be used to identify specific biomarkers even with low abundance. The identification of such biomarkers will not only facilitate the distinction between sensitisers and non-sensitisers but might well indicate potency also.
Proteomics approachesgeneral considerations
Proteomics approaches have been a late starter in the omics portfolio, as have been metabolomics. Both approaches heavily rely on mass spectroscopy (MS) and only could develop their full potential once this technique had sufficiently advanced. Before that transcriptomics was the method of choice for any cellular shot-gun analysis. However, while quantifying mRNA Fig. 2 Schematic diagram of the adverse outcome pathway (AOP) for skin sensitisation including the four proposed key events and respective validated OECD test guidelines. Adapted from the OECD. 24 Abbreviations are as follows: DPRAdirect peptide reactivity assay, hCLAThuman cell line activation test, LLNAlocal lymph node assay and GPMTguinea pig maximization test. levels using PCR-based techniques such as microarrays, RNAseq etc. is sensitive, reliable and convenient, correlation of mRNA transcript levels and expressed proteins often is poor. 40 Indeed, large scale mapping of transcriptomics and proteomics data to pathway analysis shows that the findings frequently rather complement each other than correlate. 41 With regard to physiological readouts and phenotypes the cellular proteome hence often provides more accurate information. Although the identification of low-abundant proteins still remains challenging, modern state of the art proteomics techniques can provide information on protein regulation, posttranslational modifications, protein-protein interactions and protein turnover. Compared to conventional protein analysis methods like flow cytometry, ELISA or western blot, mass spectrometry-based proteomics allow untargeted profiling of manifold proteins at the same time. This facilitates the identification of significantly altered proteins off the cuff.
However, the parallel identification and quantification of a plethora of proteins in a complex biological matrix also imposes critical technical and scientific challenges. The generation of huge amounts of complex data necessitates the thorough use of bioinformatics and statistics in order to exclude artefacts and outliers. Besides, the complex sample preparation can be rather time consuming and will add to the systematic error. Samples are usually extracted from tissue or cells, further purified by techniques such as gel electrophoresis or differential centrifugation. In particular the analysis of low-abundant proteins often requires specific enrichment strategies such as sub-cellular fractionation prior to the analysis. In bottom-up or shotgun proteomics the proteins are then usually subjected to enzymatic digestion mostly using trypsin. The resulting peptides typically have to be separated further by liquid chromatography (LC) before they can be analysed by mass spectrometry for protein identification and quantitation. Peptide masses are then compared to predicted masses from sequence databases by means of their mass-tocharge ratio (m/z). In addition, peptides can be further fragmented during an MS/MS experiment which allows sequencing of the analysed peptides as well as identification of posttranslational modifcations. 42, 43 This successive approach of proteolytic digestion followed by mass spectrometry allows the identification of proteins even from complex mixtures. Contrastingly, analysis of intact proteins provides higher sequence coverage but is predominantly performed for individual proteins.
Quantification of proteins can be achieved using several well established methods, the most frequent being two-dimensional polyacrylamide gel electrophoresis (2D-PAGE), stable isotope labelling with amino acids in cell culture (SILAC), isobaric mass tags or more recently label-free quantitation. Being the first established approach, 2D-PAGE represents a straightforward separation technique for complex protein mixtures according to isoelectric point and molecular weight. 44, 45 The unique strength of 2D-based proteomics relies on the power to resolve different modifications of a single protein, i.e. the analysis of so-called protein species, which is yet still unmatched in other approaches. 46 A major drawback of 2D-PAGE methods is the poor solubility of hydrophobic proteins in aqueous buffers which eventually results in discrimination of membrane proteins and other lipophilic proteins. Label-based methods such as SILAC follow a different approach. SILAC relies on the cultivation of cells in cell culture medium-containing isotope labelled amino acids and is therefore ideally suited to quantitatively track expression changes following exposure to an external trigger (e.g., investigating signalling pathways, post-translational modifications, metabolic incorporation of amino acids and treatment induced changes in protein abundance). A common approach is the comparison of treatment samples from 13 C 6 -lysine-and 13 C 6 -arginine-containing medium with controls grown in presence of 12 C-amino acids. Heavy amino acids are incorporated in proteins with the same efficiency as light ones and hence after five complete cell doublings typically 97% of the proteome will be present in the heavy state. 47 Only after complete label incorporation the treatment samples are exposed to test substances, unified with the control population and subjected to tryptic digestion and mass analysis. Peptides of the control and treatment will appear in the MS spectrum with a mass shift of 6 Da, if the above mentioned labelled amino acids have been used. Other labels for arginine and lysine exist as well, which may result in a different mass shift. However, the principle of quantification will remain the same. Peptide pairs can be quantified by means of their relative peak intensity in the mass spectrum, which allows the quantitation of changes in protein expression. 47, 48 An adaption of the original protocol is pSILAC ( pulsed SILAC) which enables the quantification of protein translation over a time course using multiple heavy state isotopes. 49 If metabolic labelling of proteins is not feasible, for example when working with primary cells or tissues, isobaric tagging such as iTRAQ (isobaric tag for relative and absolute quantification) is the method of choice. With iTRAQ currently a maximum of ten samples can be processed in parallel, pooled and analysed with LC-MS/MS. Tagged proteins will appear as a single peak in MS mode but once subjected to MS/ MS they will fragment in specific reporter ions due to the tag. The relative peak intensity in the mass spectrum allows calculation of protein ratios between the different treatment groups. 50, 51 Finally, label-free methods rely on the relative quantitation of proteins based on the signal intensity of the precursor ion or the number of matching spectral counts. 52, 53 They require high resolution mass spectrometers as well as a stable chromatographic system. The accurate identification of peptides is usually based on complex computational algorithms that accommodate for any retention time bias due to instable LC separation. Since samples are not pooled before sample preparation for MS, label-free quantitation is also more susceptible to experimental variations.
The complex sample handling of proteomics requires a high degree of standardisation in order to obtain reliable quantitative readouts. Hence sample complexity remains an issue and while proteomics can and have been applied to identify proteins in human skin biopsies (e.g., HSP27 as biomarker for irritants), 54 most studies tend to minimise sample complexity and focus on specific cell types and their interactions.
Haptenation
There is a huge diversity of skin proteins potentially available for chemical modification. Together with the non-stoichiometric binding of many allergens and low hapten-modified protein abundance this entails major analytical challenges. Therefore most research so far was done in chemico by using model proteins or peptides. For example the reactivity of contact allergens towards nucleophilic model peptides containing cysteine and lysine led to the adaption of the direct peptide reactivity. 25, 28 While mass spectrometry was initially used to identify and verify the haptenation sites on the model peptides, 28, 55, 56 the final guideline prescribes UV-detection as a readout. Nevertheless, there is ongoing research on the MSbased identification of further haptenation sites on model peptides for the assessment of yet unclassified chemicals. [57] [58] [59] The extreme sensitiser 2,4-dinitrochlorobenzene (DNCB) was shown to modify multiple nucleophilic residues in human serum albumin (HSA) but no further evidence for covalent binding of irritants and non-sensitisers to HSA was found. 60 Haptenation of DNCB with two abundant skin proteins revealed lysine, tyrosine and cysteine as targets for nucleophilic substitution reactions. Tyrosine was found to be most frequently modified in cytokeratin 14, whereas lysine was predominantly modified in cofilin. This discrepancy has been explained with the carbamylation of lysine residues in keratin 14 since the modification of tyrosines clearly relied on the alteration of neighbouring lysines. 61 In concordance with these findings another study identified 34 residues, predominantly lysine, modified by DNCB in HSA in a time-and dosedependent manner. Interestingly, not only the amount of modifications increased over time but also the sites, which is supportive for haptenation-induced changes in the tertiary structure. 62 A common tool for the identification of specific target residues is the use of model peptides, particularly peptides 21 and 20. As the name suggest the first one consists of all 20 proteinogenic amino acids (with lysine incorporated twice), while peptide 20 lacks cysteine. In combination they are a useful tool to investigate thiol-specific reactivity. Thiol-dependent adduct formation has been reported for DNCB and dinitrobenzenesulfonic acid (DNBS). The latter also succeeded in covalently binding to HSA and 15 other proteins in human monocytederived iDCs. The respective modified iDCs and iDCs pre-incubated with DNBS-modified HSA were eventually able to stimulate naïve T cells in vitro. 63 The thiol-dependent depletion of the model peptides by binding of contact allergens is also key to the MALDI-MS-based allergen-peptide/protein interaction assay. 64 The potent allergen PPD showed a similar thiol-dependent specificity 65 and was found to solely bind to Cys 34 in HSA, with mass spectrometry revealing a 1 : 1 stoichiometric ratio of PPD and HSA. Noticeably, PPD bound to HSA also fea-tures a higher potency for inducing T cell proliferation than in the unbound state. 66 Guedes et al. identified 39 fluorescein isothiocyanate (FITC) modified proteins in THP-1 cells, out of which approximately 30% are known to be part of or associated with the cell membrane. Amongst these proteins were for example the 78 kDa glucose-regulated protein (GRP78) and a protein of the mitogen-activated protein kinase (MAPK) family. 67 The latter was reported to have a major impact on DC maturation following exposure to contact allergens. 68, 69 FITC was found to modify a lysine residue close to the active centre of mixedlineage protein kinase 3 (MLK3), leading to inhibition of the MAPK signalling cascade and, in consequence, to reduced activation of p38 MAPK, c-Jun N-terminal kinase (JNK) and extracellular signal-regulated kinase (Erk) pathways. Likewise treatment with FITC reduced the pathways' inductive capacity following exposure of THP-1 to lipopolysaccharide (LPS) and 2,4dinitrofluorobenzene (DNFB). 67 Another intensively studied contact allergen due to its high prevalence is nickel (Ni). In human Raji B cells Ni was found to bind to 28 proteins, mainly heat shock proteins and other chaperones as well as proteins of the cytoskeleton. Notably, direct binding of Ni ions was demonstrated for the TRiC/CCTcomplex 70 and heat shock protein 70 (HSP70). 71 TRiC/CCT is believed to be engaged in the processing of antigens for presentation on MHC class I, while HSP70 plays an important role in DC activation and thus in the induction of an immune response. Concomitantly a study on potential epidermal Ni chelators also identified HSP70 as direct interaction partner of Ni. Meanwhile, the abundant Ni chelation by keratin or filaggrin in the epidermis seems to have a protective function. Null mutants of fillagrin for example have a higher risk of developing ACD, presumably because the lack of filaggrin and its Niscavenging histidines facilitates skin penetration of Ni − ions. 72 Altogether the various approaches have so far resulted in the identification of a limited set of target proteins for allergen binding (Table 1) . Similarly irritants appear to have a high affinity for nucleophilic binding but are apparently less target-specific. A proteomics study with SDS identified 653 modified proteins from human skin, with an average nucleophilic proportion of 17%. Bound targets comprised groups as diverse as keratins, proteases (e.g., caspase-14), cathepsins, numerous heat shock proteins as well as proteins known to be engaged in antioxidant defense such as catalase, superoxide dismutase and peroxiredoxin. However, direct incubation of skin biopsies with SDS for 4 hours did not lead to the identification of any specifically regulated proteins or haptenation sites. 73 Conversely, Simonsson et al. identified keratins K5 and K14 in basal keratinocytes as key targets of bromobimanes in human skin ex vivo, with LC-MS confirming specific binding to cysteine 54 in K5. 74 
Keratinocytes
The secretion of cytokines like IL-1α, IL-1β and IL-18 is fundamental in the induction of ACD. Unsurprisingly the cytokine patterns expressed by keratinocytes have been extensively studied with regard to their use for future in vitro assays. [75] [76] [77] [78] [79] [80] [81] [82] Yet, most of these studies focus on the cytokines or the underlying gene induction and not so much on the accompanying proteome changes in the cells. Nevertheless, strong allergens such as DNCB have been found to be potent inducers of protein expression in human primary keratinocytes. Exposure to DNCB led to 549 differentially regulated protein spots on a 2D gel, whereas the moderate Ni 2+ ion only induced 130 spots. Particularly affected were proteins related to glycolysis, protein folding and cellular stress response, with HSP90 featuring an allergen-specific but irritant-negative response. 83 
T cells
Assays investigating the activation of T cells commonly rely on co-cultures of antigen sensitive DCs together with T cells. 63, [84] [85] [86] [87] [88] [89] While the most common readouts of these assays are cell proliferation and secretion of cytokines such as TNF-α and IFN-γ the corresponding T cells can also be expected to undergo specific proteome changes. Jurkat cells for example react to tulipalin A with the up-regulation of at least 90 gel spots, 64 of which were identified by mass spectrometry. 90 Pathway analysis assigned these predominantly to the processes of apoptosis, cell cycle, purine synthesis, DNA repair, stress response and protein folding. The latter group included the three heat shock proteins HSP90AA1, HSP90AB1 and HSP90B1 as well as CCT3, CCT6 and CCT8 that are appertained to the TRiC, 90 a complex linked already earlier to Niinduced ACD. 70 While further studies on allergen-specific proteomics changes have to our knowledge not been published, several data sets exist that looked at the proteome of different T cell subsets in their naïve or stimulated form. [91] [92] [93] [94] [95] [96] [97] [98] [99] 
DC activation and maturation
Studies on DC activation and maturation are mostly based on surrogates. This includes cell lines such as KG-1, 100 U937 101-103 and MUTZ-3, 101, 104, 105 as well as the human leukaemia monocytic THP-1 cell line used for the h-CLAT. 27, 34 The obvious reasons are the ease of accessibility for these functional models and the lower variability of results compared to primary cell models. A great deal of effort has gone into their phenotypical characterisation and particularly for THP-1 the ACD-relevant expression of surface markers has been the subject of numerous studies. [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] Likewise, second messenger patterns of THP-1 were characterised in support of their application in the h-CLAT protocol. 115 Alternatively to the aforementioned model surrogates, primary cells isolated from blood donors are also commonly employed. Here especially monocyte-derived DCs (MoDCs) are the cells of choice for their frequent occurrence. Usually they are differentiated from CD14 + monocytes isolated from blood donations. Maturation can then be induced using stimuli like LPS. 100, 116 Although many of the available studies focus on the comparison of different model DCs, 117 most of these are based on flow cytometry, western blotting, other immunochemical assays 101, 104, 118 or differential gene expression. [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] Proteomics data allowing further characterisation of cellular proteins and especially the membrane proteome are scarce.
Treatment of monocytic THP-1 cells with tulipalin A led to the identification of only five differentially regulated gel spots, one of which was the protein heterogeneous nuclear ribonucleoprotein K (hnRPK). 70 Notably hnRPK was found to be down-regulated and is rather functionally linked to the cell cycle and apoptosis via activation of p53 than to immune response. 70 Another study looked at potential biomarkers for skin and respiratory sensitisation in MUTZ-3 cells using a 2D-DIGE approach. One of the proteins found to be induced following treatment with DNCB was calprotectin. Calprotectin is an agonist of Toll-like receptor (TLR) 4. Also up-regulated were glucose-6-phosphate-1-dehydrogenase and 6-phosphogluconate dehydrogenase, superoxide dismutase, heat shock protein A8, the membrane carrier SLC3A2, myeloperoxidase, S100A4 protein and thymosin beta-4-like protein. 129 Altogether a selection of 10 biomarkers allowed the effective discrimination of sensitisers and non-sensitisers (s. Table 2 for selected proteins found to be subject to allergen specific regulation).
Our lab recently applied a proteomics approach to investigate the role of Nrf2 during the development of ACD. Activity of Nrf2 correlates with CD86 expression following allergen induced activation in several DC models. Given the importance of Nrf2 as cellular regulator we hence used 2D-PAGE and LC-MS/MS to study the proteome of bone marrow-derived dendritic cells (BMDCs) from wild-type (nrf2 +/+ ) and Nrf2 knockout (nrf2 −/− ) mice after stimulation with DNCB, cinnamaldehyde (CA) and NiSO 4 , with the irritant SDS serving as comparison. The data showed a clearly exclusive up-regulation of many allergen-induced protein spots (fold change of >1.5, p < 0.05
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Toxicology Research according to Student's t-test) for the nrf2 +/+ -wild type. Compared to CA and NiSO 4 , DNCB clearly up-regulated the highest numbers of proteins spots. Also, responses were dosedependent for DNCB and CA but not for NiSO 4 . In total the study succeeded to identify some 100 proteins, most of them up-regulated and allowed us to identify several potential biomarkers for allergen-induced DC activation. Several of these candidates have previously been linked to contact allergy, such as for example the ARE-regulated proteins glutamate-cysteine ligase modifier subunit (GCLM), heme oxygenase 1 (HMOX1), aldehyde dehydrogenase, mitochondrial (ALDH2) and transaldolase (TALDO1). 130, 131 All of these were found to be altered by the treatment with CA and DNCB but not by NiSO 4 or SDS.
Other candidates such as ferritin light chain 1 (FTL1), peroxiredoxin-1 (PRDX1) and superoxide dismutase [Mn], mitochondrial (SOD2) are connected to DC biology and thus are particularly promising. Not only does their regulation appear to be dependent on Nrf2 but they have been linked to DC differentiation and maturation before. [132] [133] [134] Likewise induced in an Nrf2-dependent manner after treatment with CA, DNCB or NiSO 4 were several chaperones and proteasomal components. Again these proteins have previously been linked to Nrf2 activity 135, 136 presumably as an answer to the electrophilic stress following allergen exposure. However, they have also reported to be involved in antigen presentation 137, 138 and DC maturation. 139, 140 In this context the induction of chaperones is a common response to the increased protein translation rates during DC maturation, a notion that is also supported by the observed parallel up-regulation of proteins involved in gene expression in our study. While increased protein synthesis facilitates the phenotypic alterations during DC matu-ration, it depends on the expansion of the corresponding cellular compartments (i.e., endoplasmic reticulum (ER) and Golgi apparatus) 141, 142 and thus an enhanced glycolysis in order to fuel the substantial resulting energy needs. Befittingly the data indicate up-regulation of several glycolytic enzymes in BMDCs after treatment with the different sensitisers. Overall the apparent requirement for an enhanced glycolysis for DC activation resembles the so-called Warburg effect. 143 Originally described in the context of cancer growth the Warburg effect crucially depends on pyruvate kinase, muscle (PKM) as key enzyme and central target for its regulation. 144 Indeed we found PKM to be up-regulated in the nrf2 +/+ wild-type by both sensitisers. In line with this, Nrf2 has previously been described as an important factor for the regulation of energy metabolism. 145, 146 Altogether our findings therefore support that allergen-induced DC activation critically depends on metabolic reprogramming, accompanied by a cellular stress response, either of which depends on Nrf2.
With their bridging role between innate and adaptive immunity DCs are crucial during sensitisation and for the development of ACD. Compared to other involved cell types they undergo major changes in phenotype and function. This is particularly apparent for the membrane proteome which is subjected to extensive changes in order to enable cell migration and the priming of naïve T cells. The latter will ultimately fail without the corresponding DC proteome phenotype. Previous reports indeed indicate the priming of T cells to be hapten-specific as well as depending on co-stimulatory molecules and secreted cytokines. 13 Yet, proteomics data on DCs in this context remain scarce. Abbreviations: DNCB = 2,4-dinitrochlorobenzene, CA = cinnamaldehyde.
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One reason for this is that any DC-derived biomarkers should clearly distinguish between activation and general maturation. The first are likely to be indicative for ACD development, the latter not necessarily. One model for studying the response of DCs to exogenous stimuli is the already mentioned maturation of primary monocytes towards DCs. Initial differentiation to iDCs is generally induced with an IL-4 and GM-CSF containing cytokine cocktail. Eventual transformation to mDCs can then be induced using a broad variety of substances ranging from LPS, cytokines (e.g., IL-6 and TNF-α), vitamins, plant extracts and drugs. 41, [147] [148] [149] [150] [151] It should be noted that the expression of differentially regulated proteins during maturation strongly depends on the substance cocktail used. 133, 152, 153 Moreover analysis of the corresponding transcriptional and protein changes showed that much more genes are modified during differentiation than maturation, indicating the latter to be subject to post-transcriptional and post-translational regulation. 133, 152, 153 In consequence protein levels may stagnate or decrease as shown for calreticulin. 152 Together with the aforementioned dependence on the maturation-inducing cocktail this is a major challenge. In a recent study using murine BMDCs and macrophages CD11c was identified to be expressed in both cell types. 154 This supports earlier discussions that question the specificity of CD11c as a marker for DCs. 155 Instead MBC2 might be more suitable for BMDCs. 154 In total, 63 proteins were identified to discriminate GM-CSF-treated BMDCs from macrophages, including ATP synthase, CD180, MRC and FER1L.
Differentiation of primary human monocytes to immature MoDCs with a cocktail of GM-CSF and IL-4 led to significant up-regulation of calreticulin and MHC I enabling the cells to present processed antigens on their cell surface. Proteins related to the cytoskeleton were also found to be regulated. Whilst actin is down-regulated in iDCs, vimentin is up-regulated providing more flexibility for cell growth. 67, 156 Increased mitochondrial respiration also goes along with the differentiation of monocytes to iDCs. This was reflected by extended expression of mitochondrial enzymes, namely MnSOD, peroxiredoxin and glutamate dehydrogenase. 156 Plasma membrane focused proteomics of iDCs derived from primary human monocytes revealed that these cells express to a great extent proteins involved in antigen uptake, endocytosis or binding of pro-inflammatory cytokines. Amongst the proteins preferentially expressed in iDCs and which either play a role in endocytosis or MHC class II internalisation were TLRs, C-type lectin, CD91, CD32 and FcγRs. 157 Generally the subsequent maturation of iDCs induces the general up-regulation of proteins involved in cell motility and adhesion, chaperones, Ca 2+ binding proteins, cytoskeleton or cell signalling. 67 Treatment of iDCs with LPS is accompanied by alteration of cytoskeleton proteins. Actin and tropomyosin were up-regulated as were proteins engaged in cell motility such as lymphocyte specific protein 1. Concomitantly thioredoxins and chaperones are upregulated as part of the cellular stress response as well as in anticipation of potential T cell acquisition. 67 Similarly extracts from Echinacea purpurea ( purple coneflower) induced the up-regulation of the antioxidant defense proteins MnSOD, catalase and peroxiredoxin 6 as well as proteins of the cytoskeleton (i.e., vimentin, macrophage-capping protein and F-actin). 149 Maturation of iDCs with GM-CSF, IL-4 and LPS led to the down-regulation of integrins and proteins involved in antigen uptake (e.g., CD32, CD11a-c) in favour of proteins involved in T cell activation (i.e., CD40, CD80, CD86, HVEM, RANK and BlyS). 157 Other proteins of mature DCs involved in cell-cell interactions are PD-L1, JAM-1 and CD31. Due to their differential expression all of these have been suggested as potential biomarkers. 41 Since DCs undergo extensive reorganisation of the cell surface it is not surprising that DC maturation also affects lipid metabolism. This includes the up-regulation of fatty acid translocase (CD36) as well as downstream fatty acid binding proteins. 152 However, again the particular effects appear to depend on the cytokine cocktail used for maturation as other studies report partly contradictory results. 41, 158 To make things more complicated the proteome of myeloid DCs matured ex vivo differs significantly from that of MoDCs and KG-1 cells. 159 Benchmarked by the expression levels of typical markers for DC maturation such as fibrogen γ chain and fascin the immature model DCs were found to possess a more mature phenotype. Indeed, immature MoDCs were found to be more efficient in endocytosis and T cell activation and accordingly mature myeloid DCs show a more pronounced expression of DC maturation markers such as CD83 and CD86 along with higher levels of cytokines. 159 Nevertheless, ex vivo studies with myeloid DCs remain technically challenging as they usually represent only 1-3% of all peripheral blood mononuclear cells. One solution to overcome the small sample amounts from primary cells might be the label-free approach of Schlatzer et al., who used polyionsinic:polycytidylic acid to quantify regulated proteins from as little as 200 000 myeloid DCs. 160 In doing so they identified some 60 proteins including proteins engaged in interferon signalling as well as CCR7.
Outlook
The application of transcriptomics has generated extensive data and helped to identify key transcripts and pathways during the development of ACD. While this has helped tremendously to develop a better understanding of the molecular processes and cellular biology the often poor correlation to protein expression has been a challenge for functional biomarker identification. The recent technical developments in the field of proteomics offer promising solutions here, even more so when they are considered as part of multi-omics experiments. Such experiments can now be performed in relatively short time and at reasonable cost, while computational tools allow straightforward statistical analysis, database searches, pathways analysis and identification of biologically meaningful candidates. Furthermore, the application of integrated omics may not only lead to the identification of specific biomarkers but may also reveal information on the regulatory
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Toxicology Research pathway networks involved and thus on potential new endpoints. One promising source of endpoints in DC models (and other immune cell types) appears to be metabolic reprogramming. Albeit hints for the importance of changes in metabolism during the life cycle of immune cells have long been reported, it is only now that immunometabolism gains growing attention. Macrophages, DCs and T cells, for example, establish specific metabolic profiles depending on the subset they belong to and the activation state they are in. Changes in the interplay of metabolic pathways help to fulfil demands of certain metabolites that may be needed for anabolism, as energy source or help to exert specific immunological functions. 161 Initial data from our lab confirm this and a combined proteomics and metabolomics approach shall now be used to further investigate metabolic reprogramming in THP-1 cells. 
